The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

RecruitingOBSERVATIONAL
Enrollment

564

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2029

Conditions
GlioblastomaGlioblastoma, IDH-wildtypeGlioblastoma MultiformeGlioblastoma Multiforme, AdultGlioblastoma Multiforme of Brain
Interventions
PROCEDURE

Tumor resection

Maximal safe resection of the tumor

PROCEDURE

Tumor biopsy

Biopsy of the tumor

Trial Locations (8)

3010

NOT_YET_RECRUITING

Inselspital Universitätsspital Bern, Bern

74076

NOT_YET_RECRUITING

Technical University Munich, Munich

94143

RECRUITING

University of California, San Francisco, San Francisco

02114

RECRUITING

Massachusetts General Hospital, Boston

Unknown

RECRUITING

University Hospital Leuven, Leuven

RECRUITING

University Hospital Heidelberg, Heidelberg

RECRUITING

Haaglanden Medical Center, The Hague

3015 GD

RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Haaglanden Medical Centre

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

Technical University of Munich

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

University of California, San Francisco

OTHER

lead

Jasper Gerritsen

OTHER